- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07921901
Comparison of Functional Inspiratory Muscle Training and Combined Exercise Training in Individuals With Type 2 Diabetes
Comparison of the Effects of Online Functional Inspiratory Muscle Training and Combined Exercise Training on Functional Capacity, Fatigue, and Balance in Individuals With Type 2 Diabetes
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that may impair exercise capacity, respiratory muscle strength, balance, and quality of life, and increase fatigue. Exercise training is an important component of diabetes management. However, the effects of functional inspiratory muscle training, which combines breathing exercises with functional movements and postural control activities, have not been sufficiently investigated in individuals with T2DM. This study aims to compare the effects of online functional inspiratory muscle training and combined exercise training on functional capacity, fatigue, and balance in individuals with T2DM. The study will also investigate changes in respiratory muscle strength, peripheral muscle strength, quality of life, and activities of daily living. This prospective, single-blind, randomized controlled trial will include 39 individuals aged 40-65 years who have been diagnosed with T2DM. Participants will be randomly assigned to three groups in a 1:1:1 ratio: a combined exercise training group, a functional inspiratory muscle training group, and a control group. Both exercise groups will participate in an eight-week home-based training program consisting of three sessions per week. Two sessions will be supervised online by a physiotherapist, while one session will be performed independently. The combined exercise training group will perform aerobic, resistance, and breathing exercises. The functional inspiratory muscle training group will perform progressive inspiratory muscle training combined with core stabilization, postural control, and functional exercises. The control group will receive physical activity counseling and an informational brochure without participating in a structured exercise intervention. Participants will be evaluated at baseline and after the eight-week intervention. The primary outcomes will be functional capacity, fatigue, and balance, assessed using the Six-Minute Walk Test, Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-F), Timed Up and Go Test, and the short version of the Activities-specific Balance Confidence Scale. Secondary outcomes will include respiratory and peripheral muscle strength, lower-extremity functional performance, diabetes-related quality of life, instrumental activities of daily living, and anthropometric measurements. This study aims to provide evidence regarding the effectiveness of online functional inspiratory muscle training compared with combined exercise training in improving physical function and balance in individuals with T2DM.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: İrem Çaylak Yetüt, PhD Student
- Numéro de téléphone: +905397685616
- E-mail: iremcaylakyetut@ogr.iuc.edu.tr
Lieux d'étude
-
-
Istanbul
-
Istanbul, Istanbul, Turquie (Türkiye), 34147
- Istanbul University-Cerrahpasa
-
Contact:
- İrem Çaylak Yetüt, PhD student
- Numéro de téléphone: +905397685616
- E-mail: iremcaylakyetut@ogr.iuc.edu.tr
-
Contact:
- Gökşen Kuran Aslan, Proffessor
- E-mail: goksen.kuranaslan@iuc.edu.tr
-
Chercheur principal:
- İrem Çaylak Yetüt, PhD student
-
Sous-enquêteur:
- Gökşen Kuran Aslan, Professor
-
Sous-enquêteur:
- Lütfullah Caştur, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Having been diagnosed with type 2 diabetes mellitus (T2DM) for at least one year and being medically stable at the time of enrollment.
- Age between 40 and 65 years of age.
- Using oral hypoglycemic medications or insulin.
- Having a pre-exercise blood glucose level between 90 and 250 mg/dL.
- Having an HbA1c level between 6.5% and 11%.
- Having access to an internet connection.
- Being able to communicate in Turkish.
- Having no visual impairment.
Exclusion Criteria:
- Having participated in an exercise program within the previous six months.
- Having a body mass index (BMI) ≥35 kg/m².
- Having type 1 diabetes mellitus.
- Having chronic obstructive pulmonary disease (COPD), interstitial lung disease, or asthma.
- Having coronary artery disease.
- Having neurological disorders.
- Having musculoskeletal problems that may prevent participation in exercise training.
- Having uncontrolled hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥120 mmHg).
- Being pregnant or breastfeeding.
- Having a thyroid disorder.
- Having diabetic ulcers or peripheral neuropathy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Groupe d'entraînement d'exercices combinés
|
Participants allocated to the combined exercise training group will receive an eight-week online exercise program supervised by a physiotherapist. The program will include aerobic, resistance, and balance exercises aimed at improving functional capacity, peripheral muscle strength, and postural balance. Exercise intensity and progression will be individualized according to each participant's functional capacity and exercise tolerance. |
|
Expérimental: Groupe de contrôle
|
Participants allocated to the control group will continue their usual medical care during the eight-week study period. They will receive general education on type 2 diabetes management, the importance of physical activity, and healthy lifestyle habits. However, they will not participate in a structured exercise program or receive functional inspiratory muscle training or combined exercise training as part of the study. |
|
Expérimental: Groupe d'entraînement musculaire inspiratoire fonctionnel
|
Participants allocated to the functional inspiratory muscle training group will receive an eight-week online inspiratory muscle training program using an inspiratory muscle training device. Training will be performed at 30-40% of maximal inspiratory pressure (MIP), for approximately 30 minutes per day, seven days per week. One session per week will be supervised online by a physiotherapist. Training intensity will be adjusted according to individual MIP measurements and exercise tolerance. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
six-minute walk distance
Délai: baseline and week 8
|
Functional capacity will be assessed using the Six-Minute Walk Test (6MWT). Participants will be instructed to walk as far as possible within six minutes. The total distance walked will be recorded in meters. Higher distances indicate better functional capacity. |
baseline and week 8
|
|
Fatigue Level Assessed by FACİT-Fatigue Scale
Délai: Baseline and week 8
|
Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) Scale. The scale consists of 13 items, with a total score ranging from 0 to 52. Higher scores indicate lower fatigue levels and better fatigue-related quality of life. |
Baseline and week 8
|
|
Dynamic Balance Assessed by Timed Up and Go Test (TUG)
Délai: Baseline and week 8
|
Dynamic balance and functional mobility will be assessed using the Timed Up and Go (TUG) Test. Participants will stand up from a chair, walk three meters, turn around, return to the chair, and sit down. The completion time will be recorded in seconds. Lower values indicate better performance. |
Baseline and week 8
|
|
Balance Confidence Assessed by Activities-specific Balance Confidence Scale (ABC)
Délai: Baseline and week 8
|
Balance confidence will be assessed using the Activities-specific Balance Confidence (ABC) Scale. Participants will rate their confidence in maintaining balance during daily activities. Scores range from 0% to 100%, with higher scores indicating greater balance confidence. |
Baseline and week 8
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Peripheral Muscle Strength Assessed by Handheld Dynamometry
Délai: Baseline and week 8
|
Peripheral muscle strength will be assessed using a handheld dynamometer (KFORCE). Muscle strength measurements will be performed bilaterally for the selected upper- and lower-extremity muscle groups using standardized testing positions. Results will be recorded in the measurement units provided by the device. Higher values indicate greater muscle strength. |
Baseline and week 8
|
|
Maximal Expiratory Pressure
Délai: Baseline and week 8
|
Expiratory muscle strength will be assessed by measuring maximal expiratory pressure (MEP) with a respiratory pressure-measuring device. Results will be expressed in cmH2O. Higher values indicate greater expiratory muscle strength. |
Baseline and week 8
|
|
Diabetes-Related Quality of Life Assessed by DQoL-BCI
Délai: Baseline and week 8
|
Diabetes-related quality of life will be assessed using the Diabetes Quality of Life Brief Clinical Inventory (DQoL-BCI). This 15-item questionnaire evaluates the impact of diabetes on daily life, satisfaction with diabetes management, and diabetes-related concerns. Changes in quality of life will be assessed before and after the eight-week intervention. |
Baseline and week 8
|
|
Instrumental Activities of Daily Living Assessed by Lawton-Brody Scale
Délai: Baseline and week 8
|
Instrumental activities of daily living will be assessed using the Lawton-Brody Instrumental Activities of Daily Living Scale. The scale evaluates independence in daily activities such as telephone use, shopping, food preparation, housekeeping, laundry, transportation, medication management, and financial management. Higher scores indicate greater independence in instrumental activities of daily living. |
Baseline and week 8
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Lower Extremity Functional Performance Assessed by the 30-Second Sit-to-Stand Test
Délai: Baseline and week 8
|
Lower extremity functional performance will be assessed using the 30-Second Sit-to-Stand Test (30STS). Participants will be instructed to stand up fully from a seated position and sit down as many times as possible within 30 seconds, without using their arms for assistance. The total number of correctly completed repetitions will be recorded. Higher repetition counts indicate better lower extremity functional performance. |
Baseline and week 8
|
|
Waist Circumference
Délai: Baseline and week 8
|
Waist circumference will be measured using a non-elastic measuring tape and recorded in centimeters (cm). Measurements will be performed using a standardized anatomical landmark and measurement procedure. Changes in waist circumference will be evaluated from baseline to the end of the eight-week intervention. |
Baseline and week 8
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Gökşen Kuran Aslan, Proffessor, Istanbul University - Cerrahpasa
- Directeur d'études: Lütfullah Caştur, MD, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IUC-T2DM-IMT-2026
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .